<DOC>
	<DOCNO>NCT01776671</DOCNO>
	<brief_summary>Phantom limb pain ( PLP ) common disorder report patient undergo amputation . Even though cause PLP remain unclear , Gabapentin widely use . The purpose study evaluate accuracy efficacy achieve use extended release Gabapentin . Reducing incidence chronic post-amputation pain improve clinical outcome postoperatively .</brief_summary>
	<brief_title>Once Daily Gabapentin Treatment Post Amputation Pain</brief_title>
	<detailed_description>Phantom limb pain ( PLP ) common disorder report patient undergo amputation peripheral vascular disease , peripheral neuropathic disease , neoplasm traumatic event . Even though cause PLP remain unclear large number treatment suggest , single treatment regimen prove long last pain relief PLP . However Gabapentin widely use well suggest recently treatment neuropathic pain . The purpose study evaluate accuracy efficacy achieve use extended release Gabapentin offer effective pain relief , improvement sleep function , decrease problematic side effect relate peak valleys drug 's short cycle patient PLP . Gabapentin clearly demonstrate effective neuropathic pain epilepsy , treatment option post amputation pain , test . Approximately , 20 patient enrol study , titration two week change pain intensity quality life obtain subsequent visit . We expect accuracy benefit reduce incidence chronic post-amputation pain improve clinical outcome postoperatively .</detailed_description>
	<mesh_term>Gabapentin</mesh_term>
	<criteria>Subject must post amputation pain persist six month . Be consider reasonably good health , opinion investigator , post amputation pain screen visit ( base upon result medical surgical history , vital sign , pulse oximetry physical examination . Be â‰¥ 18 year age time screen . Female subject eligible follow apply : Not pregnant ( negative serum pregnancy test screen visit ) ; Not lactate Consented use barrier contraceptive method avoid pregnancy begin least 10 day check continue throughout study month end study . Voluntarily provide write informed consent . Must investigator 's opinion , able comply study procedure . Hypersensitivity allergy gabapentin History coexist epilepsy uncontrolled seizure disorder Subject suffer dementia cognitive dysfunction Have uncontrolled poorly control major psychiatric condition ( e.g . schizophrenia , major depression ) clinically significant anxiety depression Severe cardiopulmonary liver disease Impaired kidney function test Patient receive hemodialysis Subjects current uncontrolled depression uncontrolled psychiatric disorder Subjects currently take anticonvulsant reason treatment History untreated alcohol abuse History gastrointestinal symptom : diarrhea , dyspepsia gastro duodenal ulcer Subjects history gastric reduction surgery Any clinically significant condition , unstable intercurrent illness would , opinion investigator , preclude study participation interfere assessment pain Clinically significant uncontrolled hypo hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>